Close menu




July 22nd, 2026 | 07:55 CEST

Millions in Losses at Eutelsat! Warning Sparks Panic at Evotec! Can Zefiro Methane Save Your Portfolio?

  • methane
  • OrphanWells
  • Satellites
  • Biotechnology
Photo credits: Pixabay

The geopolitical situation is currently escalating dramatically. The latest news from the Middle East is coming in fast and furious. A massive military exchange between the US and Iran threatens to profoundly shake the global economy. Burning oil refineries in Kuwait, dead soldiers, and wailing sirens in the Gulf state of Bahrain paint a grim picture of the current security situation. Such rapidly escalating crises are driving oil prices sky-high and have the potential to send shockwaves through international financial markets. In these particularly turbulent times, many investors are desperately seeking safe havens. While once-coveted AI and tech stocks, as well as biotech hopefuls, are collapsing under the weight of global uncertainty and, in some cases, their own internal issues, lucrative niche markets are increasingly coming into focus. Today, we take a look at three different stocks. First, we examine the severe setback at Evotec, the costly strategic hurdles at Eutelsat, and the astonishing resilience of Zefiro Methane.

time to read: 4 minutes | Author: Matthias Schomber
ISIN: ZEFIRO METHANE CORP | CA98926D1069 | NEO: ZEFI , EUTELSAT COMMS EO 1 | FR0010221234 , EVOTEC SE INH O.N. | DE0005664809

Table of contents:


    Author

    Matthias Schomber

    Matthias Schomber

    Raised in Giessen, Hesse, Matthias Schomber discovered his passion for the financial markets as early as the 1990s—at a time when stock trading was still largely the domain of true, die-hard traders. After completing his banking apprenticeship, he worked for a private bank there and witnessed the rise and fall of the Neuer Markt firsthand on the trading floor of the Frankfurt Stock Exchange, drawing lessons from the experience that continue to shape his thinking as a trader, author, and trading system developer to this day.

    About the author



    Tag cloud


    Shares cloud

    Evotec: In Free Fall Toward a Ten-Year Low

    We begin our analysis with a real problem child. The stock of the Hamburg-based biotech company Evotec has experienced an almost unprecedented bloodbath in recent weeks. Following a drastic profit warning and a sharp downward revision of its annual forecast, the stock headed in only one direction. The share price has literally plummeted and is currently trading just above its most recent ten-year low of EUR 3.17 at around EUR 3.55. Virtually nothing remains of the stock's former highs—five years ago, it was still trading above EUR 45.

    Analysts are now also pulling the plug one after another and drastically lowering their price targets. The ongoing delay of key milestone payments and severe operating losses have deeply shaken investor confidence. From a technical analysis perspective, the stock is in a massive downtrend. A viable support zone has yet to be painstakingly identified. There is pure uncertainty in the market. Anyone hoping for a quick recovery here is currently playing with fire. There is, however, a glimmer of hope. The RSI stands at 27 points, and in the past, the stock has often rebounded from that level. In any case, as the saying goes, hope dies last.

    Eutelsat: Between Heavy Losses and High Hopes

    From the depths of the biotechnology sector surrounding Evotec, we now turn our attention to space. While the situation there is different, it is by no means worry-free. In the satellite business, too, the major players are grappling with enormous financial burdens and extremely fierce competition. The French company Eutelsat is currently at the center of a heated debate. The British government, in particular, is likely to be swallowing hard as it looks at its portfolio, as the government's stake in OneWeb has now resulted in a massive book loss of around 340 million British pounds.

    Eutelsat's share price clearly reflects this investor skepticism. Trading at around EUR 2.12, the share is down more than 50% from its 52-week high of EUR 4.56. That high was likely driven in part by the hype surrounding SpaceX's recent IPO. However, since Elon Musk's space stock has recently been on a downward trend and has even fallen below its IPO price, Eutelsat was likely unable to escape this downward pull. The key 200-day moving average has already been broken significantly to the downside. Yet there are certainly bright spots in the company's operations. Revenue in the connectivity segment rose by a strong 65% year-over-year. The strategic shift toward low Earth orbit (LEO) capacity seems to be bearing fruit, at least initially. Nevertheless, operational pressure from aggressive global competitors like Starlink and Amazon remains extremely high. For now, wait for the stock to find a bottom and watch from the sidelines!

    Zefiro Methane: Tangible Solutions for a Billion-Dollar Problem

    While Eutelsat battles for market share high in orbit and Evotec desperately seeks profitability in the lab, we find another company that has identified lucrative solutions in a niche market and is reaping the rewards.

    The Canadian environmental company Zefiro Methane is tackling a mammoth task: professionally sealing decommissioned oil and gas wells that are extremely harmful to the climate. The latest developments look promising across the board.

    A strategic partnership with the renowned Well Done Foundation has secured Zefiro a lucrative contract to plug 10 wells in Oklahoma, with another 20 set to follow in 2027. In addition, the company is benefiting massively from the expansion of new AI data centers: the sites designated for these projects very often contain historical contaminated sites that must be plugged before construction can begin.

    https://youtu.be/nNodjcqNJMM

    A look at the company's financials underscores its enormous potential. Zefiro operates in a market with an estimated total volume of USD 400-600 billion. Over 2.2 million abandoned wells are awaiting closure in the US alone. Zefiro draws on generous government funding and also generates highly sought-after CO2 credits, which have already been successfully sold to companies such as Mercuria Energy and EDF Trading.

    Chart Analysis: Is Zefiro Methane on the Verge of a Technical Breakout?

    The chart pattern for Zefiro shares is particularly exciting right now. Following the dynamic breakout in May above the key CAD 0.60 level and the subsequent high of CAD 0.80, the stock is currently consolidating and trading around the CAD 0.63 level.

    A highly interesting detail is a recent candlestick pattern in the form of a hammer (see chart below). This hammer closed the open gap at exactly CAD 0.52. The market has thus technically completed a downward correction.

    If the stock sustainably rises above the CAD 0.67 level, breaking through the current consolidation line, the breakout should be considered formally successful. After that, a rapid new annual high above CAD 0.80 could be on the horizon, with medium-term potential toward the "magic" CAD 1.00 mark.

    The research firm GBC takes a similar, or even slightly more optimistic, view in its latest analysis of Zefiro Methane. It took a closer look at the company and valued it using a three-stage DCF model. As a result, it has set a price target of CAD 2.12 for the stock. So there is still plenty of room to run!

    There is significant upside potential!

    Following the sharp share price drop, Evotec is left in a shambles and must painstakingly rebuild investor confidence. However, a technical rebound cannot be ruled out due to the stock being heavily oversold. Eutelsat is showing good growth in the LEO segment but is suffering from impairment charges and fierce cutthroat competition from rivals. Zefiro Methane is positioning itself promisingly at the intersection of environmental protection and energy infrastructure. With full order books and a clean technical chart setup, the next upward surge could be just around the corner.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Matthias Schomber

    Matthias Schomber

    Raised in Giessen, Hesse, Matthias Schomber discovered his passion for the financial markets as early as the 1990s—at a time when stock trading was still largely the domain of true, die-hard traders. After completing his banking apprenticeship, he worked for a private bank there and witnessed the rise and fall of the Neuer Markt firsthand on the trading floor of the Frankfurt Stock Exchange, drawing lessons from the experience that continue to shape his thinking as a trader, author, and trading system developer to this day.

    About the author



    Related comments:

    Commented by Stefan Feulner on November 20th, 2026 | 05:55 CET

    Merck KGaA, BioNxt Solutions and Novartis – A billion-dollar market is being reshaped

    • Biotechnology

    Multiple sclerosis has long been a billion-dollar market. But as established drugs come under pressure from expiring patents, new therapeutic approaches are advancing through clinical development. The focus is not just on better active ingredients, but increasingly on easier ways of administering treatments. A German pharmaceutical group is battling generic competition, a small biotech developer is betting on a new drug delivery format, and a Swiss industry giant has reported promising Phase 3 data. This creates significant opportunities for investors, each with a different risk profile.

    Read

    Commented by Jens Castner on November 19th, 2026 | 05:33 CET

    Gold diggers and shovel sellers: SpaceX, Amazon and HPQ Silicon in the race for internet from space

    • Spaceflight
    • Satellites
    • Batteries
    • Technology
    • Data centres
    • Rechargeable batteries
    • SpaceX
    • Amazon
    • HPQ Silicon

    Created and published on behalf of HPQ Silicon

    A spacecraft lands in the launch tower's mechanical arms, while another rocket carrying 40 satellites crashes into the sea. Rarely has the race for internet dominance in space received so much media attention as it did last weekend. SpaceX and Amazon are investing billions in orbital networks and have a combined market value of around USD 4.7 trillion. But, as in every gold rush, it is primarily the shovel sellers who stand to benefit most. HPQ Silicon aims to take on that role. The little-known Canadian company has a stock market value that is only a fraction of what the two giants are worth.

    Read

    Commented by Matthias Schomber on November 16th, 2026 | 05:32 CET

    Zefiro Methane: Chance to triple! A huge market worth billions beckons! Possible chart breakout soon!

    • methane
    • methane reduction
    • methane solution
    • tripler
    • 200 %

    Created and published on behalf of Zefiro Methane Corp.
    While global stock markets continue to walk a tightrope between new records and the threat of geopolitical setbacks and falling share prices, buoyed by fresh all-time highs such as the DAX's first move above the 27,000-point mark, savvy investors are searching for fundamentally sound alternatives beyond the volatile tech, defence and AI hype, as recently illustrated by the sharp corrections in Nvidia and Rheinmetall. This is precisely where Zefiro Methane could stand out as a specialist ESG company with solid underlying substance, tackling and solving a huge environmental problem largely unnoticed by the general public. While concerns over interest rates and economic growth, as well as ballooning government debt in some countries, are causing uncertainty on major global stock markets, the company is benefiting from demand for methane well plugging that is largely independent of economic crises. Supported by the latest quarterly figures, a growing fleet and government contracts, the stock presents a compelling technical chart setup. In light of this operational momentum, analysts at research firm GBC have set a price target of USD 1.42, equivalent to around CAD 2.00. A closer look at the operational details reveals why the share could be poised for another upward move following its current consolidation phase.

    Read